Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3)
Brazil · Delayed Price · Currency is BRL 28.30
-0.20 (-0.70%)
At close: Oct 7, 2026
BVMF:OFSA3 Ratios and Metrics
Market cap in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,522 | 1,237 | 1,040 | 1,398 | 1,308 | 1,375 | |
Market Cap Growth | 28.40% | 18.86% | -25.61% | 6.91% | -4.84% | -32.95% |
Enterprise Value | 1,671 | 1,543 | 1,140 | 1,484 | 1,548 | 1,515 |
Last Close Price | 28.30 | 22.73 | 16.13 | 20.72 | 19.02 | 19.33 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.45 | 5.56 | 7.75 | - | 10.01 | 12.06 |
Forward PE | - | 11.16 | 11.16 | 14.38 | 15.50 | 15.50 |
PS Ratio | 1.11 | 1.01 | 1.01 | 1.48 | 1.26 | 1.52 |
PB Ratio | 1.84 | 1.55 | 1.38 | 2.03 | 1.78 | 2.14 |
P/TBV Ratio | 1.85 | 1.56 | 1.39 | 2.07 | 1.86 | 2.17 |
P/FCF Ratio | 7.19 | 17.45 | 18.53 | 8.46 | 34.78 | - |
P/OCF Ratio | 6.55 | 12.38 | 14.07 | 7.35 | 14.60 | 29.56 |
PEG Ratio | - | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.22 | 1.26 | 1.11 | 1.57 | 1.49 | 1.68 |
EV/EBITDA Ratio | 5.38 | 5.87 | 5.42 | 11.71 | 7.92 | 9.24 |
EV/EBIT Ratio | 5.92 | 6.38 | 6.05 | 14.45 | 8.94 | 10.50 |
EV/FCF Ratio | 7.90 | 21.77 | 20.31 | 8.97 | 41.15 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.63 | 0.63 | 0.50 | 0.64 | 0.56 | 0.60 |
Debt / EBITDA Ratio | 1.67 | 1.87 | 1.73 | 3.38 | 2.09 | 2.32 |
Debt / FCF Ratio | 2.45 | 7.11 | 6.68 | 2.65 | 10.96 | - |
Net Debt / Equity Ratio | 0.18 | 0.32 | 0.19 | 0.19 | 0.34 | 0.35 |
Net Debt / EBITDA Ratio | 0.49 | 0.96 | 0.67 | 1.05 | 1.26 | 1.35 |
Net Debt / FCF Ratio | 0.71 | 3.57 | 2.52 | 0.81 | 6.58 | -23.51 |
Asset Turnover | 0.93 | 0.83 | 0.77 | 0.72 | 0.82 | 0.79 |
Inventory Turnover | 1.67 | 2.05 | 2.14 | 1.92 | 1.72 | 1.99 |
Quick Ratio | 2.33 | 2.42 | 2.13 | 2.64 | 1.96 | 1.83 |
Current Ratio | 3.61 | 3.55 | 3.06 | 3.56 | 3.25 | 2.97 |
Return on Equity (ROE) | 31.81% | 28.63% | 18.58% | -7.01% | 18.97% | 18.96% |
Return on Assets (ROA) | 11.98% | 10.24% | 8.84% | 4.89% | 8.52% | 7.86% |
Return on Invested Capital (ROIC) | 29.29% | 24.84% | 16.61% | -10.47% | 16.66% | 16.63% |
Return on Capital Employed (ROCE) | 21.60% | 18.90% | 17.20% | 9.80% | 15.90% | 15.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 15.52% | 17.98% | 12.91% | -3.57% | 9.99% | 8.29% |
FCF Yield | 13.90% | 5.73% | 5.40% | 11.83% | 2.88% | -0.68% |
Dividend Yield | 4.56% | 5.67% | 3.57% | 2.96% | 1.03% | - |
Payout Ratio | 26.64% | 15.74% | 13.53% | - | 25.43% | 31.24% |
Buyback Yield / Dilution | - | - | - | - | 0.27% | 0.06% |
Total Shareholder Return | 4.56% | 5.67% | 3.57% | 2.96% | 1.31% | 0.06% |